1. Cost-utility and cost-benefit analysis of TAVR availability in the US severe symptomatic aortic stenosis patient population. (31st December 2022) Authors: Sevilla, J. P.; Klusty, Jessica M.; Song, Younghwan; Russo, Mark J.; Thompson, Christin A.; Jiao, Xiayu; Clancy, Seth J.; Bloom, David E. Journal: Journal of medical economics Issue: Volume 25:Number 1(2022) Page Start: 1051 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗